|
| |
dendritic cell vaccine avax Pages on BioPortfolio:
BioPortfolio - Immunotherapy
Dendritic Cells: A Critical Player in Cancer Therapy? ... AVAX Technologies is a development stage biopharmaceutical company which is acquiring and ...
http://www.bioportfolio.com/indepth/immunotherapy.html...
|
BioNews Biotechnology, Pharmaceutical, Life Science & Medical News ...
Dendritic cells fused with human cancer cells described - Cancer Vaccine ... 2005 JAN 19 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
The Emerging Cancer Vaccine Market, 2nd Edition
O-VAX Autologous Cell Vaccine PX 104.1 TroVAX Dendritic Cell/Tumor Cell Fusion ... Avax Technologies, Inc. Biomira, Inc. Biovest International, Inc. Cell ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_79.html...
|
BioNews Biotechnology, Pharmaceutical, Life Science & Medical News ...
NewsRxVaccines via NewsEdge Corporation : 2004 DEC 29 - (NewsRx.com & NewsRx.net ) -- Dendritic cell-tumor cell hybrid vaccination benefits metastatic cancer ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
GSK's Cervarix a future blockbuster of 2007
Gene modified cancer vaccines 2.7.3. Dendritic cell cancer vaccines ... Key players in therapeutic cancer vaccines 4.1.1. AVAX Technologies and M-Vax ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_749.html...
|
BioPortfolio - Immunotherapy
[Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine.] Up to date, most attempts to use immunotherapy to
...
http://www.bioportfolio.com/indepth/Immunotherapy.html...
|
Cancer Immunotherapies and Vaccines - Pipeline Analysis and ...
Dendritic Cell Immunotherapies/Vaccines DNA and Viral Vector Vaccines 4.2 Setbacks ... AVAX Technologies GlaxoSmithKline IDM Pharma Introgen Therapeutics
...
http://www.bioportfolio.com/cgi-bin/acatalog/info_593.html...
|
BioPortfolio - biovex for melanoma
The company BioVEX have successfully developed viruses to load dendritic cells with ... When mice were inoculated with B16 melanoma cells, tumors rapidly . ...
http://www.bioportfolio.com/search/biovex_for_melanoma.html...
|
Can therapeutic vaccines fulfill their promise?
The first three therapeutic vaccines to have reached the market - Avax Technologies' ... dendritic cells, conjugated vaccines and anti-idiotype
vaccines. ...
http://www.bioportfolio.com/biotech_news/Datamonitor_8.htm...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
Mesoblast encouraged by early stem cell results Business Spectator Oct 13 2008 12:51AM. Gift to Center Raises Questions Washington Post Oct 13 2008 12:46AM ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
[Cancer vaccinotherapy: from the experiment to cli...[Vestn Ross ...
2000]; Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax. [BioDrugs. 2003]; Dendritic cell based vaccines: progress in immunotherapy studies for prostate
...
http://www.ncbi.nlm.nih.gov/pubmed/18050681...
|
Cancer vaccines, a critical review - Part I Malcolm S Mitchell
the presentation of an exogenous antigen by a dendritic cell ..... part of the AVAX autologous cell vaccine development. program in Europe (AVAX ...
http://www.biomedcentral.com/content/pdf/cd-437985.pdf...
|
Tumor vaccines: a role in preventing recurrence in...[Am J Clin ...
2006]; Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax. [BioDrugs. 2003]; Autologous, allogeneic tumor cells or genetically engineered cells as cancer ...
http://www.ncbi.nlm.nih.gov/pubmed/12444803...
|
BioWorld Today
In Miller's opinion, Dendreon's autologous dendritic cell vaccine Provenge ... AVAX Technologies Inc. expects data in 2010 from its Phase III melanoma trial
...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
The role of vaccine therapy in the treatment of me...[Expert Opin ...
Results: Melanoma vaccines can be classified into six groups: whole-cell vaccines, dendritic cell vaccines, peptide vaccines, ganglioside vaccines, ...
http://www.ncbi.nlm.nih.gov/pubmed/18294102...
|
GSK's Cervarix a future blockbuster of 2007
Gene modified cancer vaccines 2.7.3. Dendritic cell cancer vaccines ... Key players in therapeutic cancer vaccines 4.1.1. AVAX Technologies and M-Vax ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_749.html...
|
Characterization of tumor vaccines during product ...[Vaccine ...
[Drugs R D. 2007]; Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax. [ BioDrugs. 2003]; Idiotypic vaccination for B-cell malignancies as a model for
...
http://www.ncbi.nlm.nih.gov/pubmed/11090716...
|
Cancer vaccines: A critical review on clinical impact Roberto J Bitton
(AVAX Technologies Inc), a dinitrophenyl-modified. autologous melanoma cell vaccine [31]. Dendritic cell vaccines. DCs have evolved along with the immune
...
http://www.biomedcentral.com/content/pdf/cd-523093.pdf...
|
Sipuleucel-T: APC 8015, APC-8015, prostate cancer ...[Drugs R D ...
Sipuleucel-T [APC 8015, Provenge] is an autologous, dendritic cell-based vaccine under .... 2003]; Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax. ...
http://www.ncbi.nlm.nih.gov/pubmed/16752945...
|
The Emerging Cancer Vaccine Market, 2nd Edition
O-VAX Autologous Cell Vaccine PX 104.1 TroVAX Dendritic Cell/Tumor Cell Fusion ... Avax Technologies, Inc. Biomira, Inc. Biovest International, Inc. Cell ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_79.html...
|
|
